US4888281A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of catalyzing chemical reactions
Assignee: Wellstat Biocatalysis LLC
•
Filing: 1984-11-27
•
Granted: 1989-12-19
•
Expires: 2004-11-27
Abstract
Abstract A method for increasing the rate of chemical reactions involving the conversion of at least one reactant to at least one product involves contacting the reactant with an appropriate monoclonal antibody under conditions permitting the formation of a complex between the antibody and the reactant. The complexed reactant is converted to the product which is then released from the complex. The monoclonal antibody may employ a cofactor and may be directed to a known substrate of an enzyme. Methods for preparing such monoclonal antibodies are also disclosed.
Inventors
- 👤 Gerald Schochetman
- 👤 Richard J. Massey
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 16:51
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/08; C07K16/10; C07K16/112; C07K16/114; C07K16/1145; B; B82; B82Y; B82Y5/00; C07K16/42; C07K16/4208; C07K16/4241; C07K16/44; C12; C12N; C12N9/00; C12N9/0002; C12P; C12P1/00; C12P13/00; C12P13/04; C12P13/22; C12P13/227; C12P17/00; C12P17/10; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/34; C12P41/00; C12P41/003; C12P41/004; C12Q; C12Q1/00; C12Q1/25; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N33/535; G01N33/536; G01N33/542; G01N2333/00; G01N2333/005; G01N2333/08; G01N2333/15; G01N2333/155; G01N2333/16; G01N2333/90; G01N2333/914; G01N2333/948; G01N2333/95; G01N2333/964; G01N2333/96425; G01N2333/96427; G01N2333/9643; G01N2333/96472
Claims Analysis
Total Claims: 31
Claim 1
Independent Claim
186 words
A method for catalyzing a chemical reaction wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody having been produced by a process comprising the steps of: (a) generating a plurality of monoclonal antibodies to an antigen selected from the group consisting of: (i) the reactant, (ii) the reactant bound to a peptide of other carrier molecule, (iii) a reaction intermediate, (iv) an analog of the reactant, (v) an analog of the product in which the monoclonal antibody so generated is capable of binding to the reactant or a reaction intermediate, and (vi) an analog of a reaction intermediate, and (b) screening said plurality of monoclonal antibodies to identify a monoclonal antibody which catalyzes the reaction.
Claim 2
Independent Claim
186 words
A method for catalyzing a chemical reaction wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody having been produced by a process comprising the steps of: (a) generating a plurality of monoclonal antibodies to an antigen selected from the group consisting of: (i) the reactant, (ii) the reactant bound to a peptide of other carrier molecule, (iii) a reaction intermediate, (iv) an analog of the reactant, (v) an analog of the product in which the monoclonal antibody so generated is capable of binding to the reactant or a reaction intermediate, and (vi) an analog of a reaction intermediate, and (b) screening said plurality of monoclonal antibodies to identify a monoclonal antibody which catalyzes the reaction.
Claim 3
Dependent Claim
17 words
A method as recited in claim 1 wherein one reactant is converted to one or more products.
Claim 4
Dependent Claim
19 words
A method according to claim 2 wherein the reactant is a polysaccharide and the products are saccharides derived therefrom.
Claim 5
Dependent Claim
20 words
A method according to claim 2 wherein the reactant is a polynucleotide and the products are nucleotide fragments derived therefrom.
Claim 6
Dependent Claim
22 words
A method according to claim 2 wherein the reactant is a β-galactoside and at least one of the two products is galactose.
Claim 7
Dependent Claim
17 words
A method as recited in claim 1 wherein two reactants are converted into one or more products.
Claim 8
Dependent Claim
25 words
A method as recited in claim 1 wherein the reaction is a reaction which is also capable of being catalyzed by a nonproteinaceous organic molecule.
Claim 9
Dependent Claim
18 words
A method as recited in claim 7 wherein said nonproteinaceous organic molecule is a cofactor and an reaction.
Claim 10
Dependent Claim
13 words
A method as recited in claim 8 wherein the cofactor is pyridoxal phosphate.
Claim 11
Dependent Claim
23 words
A method as recited in claim 1 wherein the reaction is a reaction which is also capable of being catalyzed by an enzyme.
Claim 12
Dependent Claim
19 words
A method as recited in claim 10 wherein an effective amount of an enzyme is present in the reaction.
Claim 13
Dependent Claim
31 words
A method as recited in claim 11 wherein the reaction involves the exchange of an amino group from a reactant to a product and wherein the enzyme is a transaminase enzyme.
Claim 14
Dependent Claim
27 words
A method as recited in claim 11 wherein the reaction involves cleavage of a phosphodiester bond in a polyribonucleotide and wherein the enzyme is a restriction enzyme.
Claim 15
Dependent Claim
22 words
A method as recited in claim 11 wherein the reaction involves cleavage of a galactosyl linkage and wherein the enzyme is β-galactosidase.
Claim 16
Dependent Claim
21 words
A method as recited in claim 11 wherein the reactant is a cyclic polynucleotide and the product is a linear polynucleotide.
Claim 17
Dependent Claim
30 words
A method as recited in claim 1 wherein the reactant is complexed with more that one monoclonal antibody, each of which is directed to a different determinant on the reactant.
Claim 18
Dependent Claim
26 words
A method as recited in claim 16 wherein the reactant is a polynucleotide and the monoclonal antibodies are directed to different nucleotide sequences within the polynucleotide.
Claim 19
Dependent Claim
33 words
A method as recited in claim 1 wherein the rate of reaction in the presence of the monoclonal antibody is more than 100 times the rate in the absence of the monoclonal antibody.
Claim 20
Dependent Claim
46 words
A method as recited in claim 1 wherein the reaction is carried out in an aqueous solution at a pH between 6.0 and 8.0, at ambient pressure, at a temperature of 4° C. to 50° C. and at an ionic strength of less than 2.0 moles/liter.
Claim 21
Independent Claim
307 words
A method for catalyzing a chemical reaction wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody being characterized by a K>1, where K=k r /k p , K r is the affinity constant of the monoclonal antibody for the product, and wherein said chemical reaction is characterized by an r 1 >r o , where r 1 is the rate of formation of the complex between the antibody and the reactant and where r o is the rate of the chemical reaction in the absence of monoclonal antibody, by an r 2 >r o , where r 2 is the rate of the conversion of the complexed reactant to the complexed product and by a r 3 >r o , where r 3 is the rate of release of the product from the complex, said monoclonal antibody having been produced by a process comprising the steps of: (a) generating a plurality of monoclonal antibodies to an antigen selected from the group consisting of: (i) the reactant, (ii) the reactant bound to a peptide or other carrier molecule, (iii) a reaction intermediate, (iv) an analog of the reactant, (v) an analog of the product in which the monoclonal antibody so generated is capable of binding to the reactant or a reaction intermediate, and (vi) an analog of a reaction intermediate, and (b) screening said plurality of monoclonal antibodies to identify a monoclonal antibody which catalyzes the reaction.
Claim 22
Independent Claim
307 words
A method for catalyzing a chemical reaction wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody being characterized by a K>1, where K=k r /k p , K r is the affinity constant of the monoclonal antibody for the product, and wherein said chemical reaction is characterized by an r 1 >r o , where r 1 is the rate of formation of the complex between the antibody and the reactant and where r o is the rate of the chemical reaction in the absence of monoclonal antibody, by an r 2 >r o , where r 2 is the rate of the conversion of the complexed reactant to the complexed product and by a r 3 >r o , where r 3 is the rate of release of the product from the complex, said monoclonal antibody having been produced by a process comprising the steps of: (a) generating a plurality of monoclonal antibodies to an antigen selected from the group consisting of: (i) the reactant, (ii) the reactant bound to a peptide or other carrier molecule, (iii) a reaction intermediate, (iv) an analog of the reactant, (v) an analog of the product in which the monoclonal antibody so generated is capable of binding to the reactant or a reaction intermediate, and (vi) an analog of a reaction intermediate, and (b) screening said plurality of monoclonal antibodies to identify a monoclonal antibody which catalyzes the reaction.
Claim 23
Dependent Claim
37 words
A method as recited in claim 20 wherein said reaction is one which is also capable of being catalyzed by a cofactor or by an enzyme and wherein a cofactor or enzyme is present in said reaction.
Claim 24
Dependent Claim
16 words
A method as recited in claim 1 wherein said antigen is an analog of the reactant.
Claim 25
Dependent Claim
36 words
A method as recited in claim 1 wherein said reaction is one which is also capable of being catalyzed by a cofactor or by an enzyme and a cofactor or enzyme is present in said reaction.
Claim 26
Dependent Claim
33 words
A method as recited in claim 1 wherein the monoclonal antibody identified in step (b) is produced in quantity by culturing a plurality of hybridoma cells each of which produces said monoclonal antibody.
Claim 27
Independent Claim
187 words
A method for catalyzing a chemical reaction wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody having been produced by a process comprising the steps of: (a) immunizing an animal with an analog of the reactant, and thereby generating antibody-producing lymphocytes is said animal; (b) removing said antibody-producing lymphocytes from said animal; (c) fusing said antibody-producing lymphocytes with myeloma cells and thereby producing a plurality of hybridoma cells each producing monoclonal antibodies; (d) screening said plurality of monoclonal antibodies to identify a monoclonal antibody which catalyzes the desired reaction; and (e) producing a quantity of the monoclonal antibody identified in step (d) by culturing a plurality of hybridoma cells, each of which produces said monoclonal antibody.
Claim 28
Independent Claim
187 words
A method for catalyzing a chemical reaction wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody having been produced by a process comprising the steps of: (a) immunizing an animal with an analog of the reactant, and thereby generating antibody-producing lymphocytes is said animal; (b) removing said antibody-producing lymphocytes from said animal; (c) fusing said antibody-producing lymphocytes with myeloma cells and thereby producing a plurality of hybridoma cells each producing monoclonal antibodies; (d) screening said plurality of monoclonal antibodies to identify a monoclonal antibody which catalyzes the desired reaction; and (e) producing a quantity of the monoclonal antibody identified in step (d) by culturing a plurality of hybridoma cells, each of which produces said monoclonal antibody.
Claim 29
Independent Claim
217 words
A method for catalyzing a chemical reaction which is known to be catalyzed by an enzyme and wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody having been prepared by a process comprising the steps of: (a) generating a plurality of monoclonal antibodies to said enzyme; (b) screening said plurality of monoclonal antibodies to identify a first monoclonal antibody which inhibits binding of the reactant to the enzyme; (c) recovering the said first monoclonal antibody; (d) generating a plurality of anti-idiotype monoclonal antibodies to the said first antibody recovered in step (c); (e) screening said plurality of anti-idiotype monoclonal antibodies generated in step (d) to identify a second monoclonal antibody which binds the reactant and catalyzes the desired reaction; and (f) producing a quantity of the monoclonal antibody identified in step (e) by culturing a plurality of hybridoma cells, each of which produces said monoclonal antibody.
Claim 30
Independent Claim
217 words
A method for catalyzing a chemical reaction which is known to be catalyzed by an enzyme and wherein at least one reactant is converted to at least one product comprising the step of: contacting the reactant with at least one monoclonal antibody capable of catalytically increasing the rate of conversion of reactant to product in said chemical reaction, said contact being performed under conditions wherein a complex is formed between said monoclonal antibody and said reactant, the said reactant is catalytically converted to said product, and the said product is released from said complex, said monoclonal antibody having been prepared by a process comprising the steps of: (a) generating a plurality of monoclonal antibodies to said enzyme; (b) screening said plurality of monoclonal antibodies to identify a first monoclonal antibody which inhibits binding of the reactant to the enzyme; (c) recovering the said first monoclonal antibody; (d) generating a plurality of anti-idiotype monoclonal antibodies to the said first antibody recovered in step (c); (e) screening said plurality of anti-idiotype monoclonal antibodies generated in step (d) to identify a second monoclonal antibody which binds the reactant and catalyzes the desired reaction; and (f) producing a quantity of the monoclonal antibody identified in step (e) by culturing a plurality of hybridoma cells, each of which produces said monoclonal antibody.
Claim 31
Dependent Claim
17 words
A method as recited in claim 1 wherein said antigen is an analog of a reaction intermediate.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-12-18 | 1993-06-19 | 1993-12-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-12-18 | 1997-06-19 | 1997-12-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-12-18 | 2001-06-19 | 2001-12-19 | $7700.00 | Window Closed / Lapsed |